International Directory of Plasma Fractionators – 2020
Announcement
INTERNATIONAL DIRECTORY OF PLASMA FRACTIONATORS 2020
& Forecast to 2030
The report entitled International Directory of Plasma Fractionators 2020 & Forecast to 2030 is now available. It updates our 2018 report with a complete listing of the major commercial and non-profit organizations that front fractionate human plasma into therapeutic proteins in each region and globally. The following data are provided for each fractionation plant, when available, (over 75 in total):
• Fractionation capacity, throughput and utilization
• Type of Plasma Fractionated (Recovered vs Source).
• Legal status (Parent Owner for each plant), and
• Contact Information (address, email and website),
Together, this information is analyzed to create a global comparison of fractionation plants, their capacity, throughput and utilization by company and region.
The forecast is based on the 2020 global information and uses the Marketing Research Bureau’s extensive industry contacts and primary research to create estimates of the fractionation capacities and throughputs of all the fractionation plants globally to the year 2030, starting with historical data from 2016. This helps the reader understand the expected growth of the industry on a company and regional basis, along with future throughput and plasma production volumes for key products.
THE INTERNATIONAL DIRECTORY OF PLASMA FRACTIONATORS — 2020
TABLE OF CONTENTS of the Current Report
EXECUTIVE SUMMARY
INTRODUCTION: BACKGROUND & METHODOLOGY
FRACTIONATION PLANT CAPACITIES IN 2020
Regional Distribution of Plants & Front Fractionation Capacity
Largest Fractionators by Capacity in 2020
FRACTIONATION PLANT THROUGHPUT & UTILIZATION IN 2020
Regional Distribution of Plasma Throughput & Plant Utilization
Largest Fractionators by Throughput in 2020
Type of Plasma Fractionated (Source vs. Recovered)
FRACTIONATION CAPACITY AND THROUGHPUT FORECAST TO 2030
FORECAST ASSUMPTIONS
Impact of Economic Fluctuations on Individual Company Forecasts
Regional Fractionation Throughput
No Acquisitions or Permanent Closures of Plants Assumed in Forecast
Utilization Rates & Preferences
Immunoglobulin Demand and Plasma Collection Trends
FORECAST OF FRACTIONATION PLANT THROUGHPUT TO 2030
Forecast of the Largest Fractionators by Throughput in 2030
Origin of Plasma for Fractionation
FORECAST OF FRACTIONATION PLANT CAPACITIES & UTILIZATION TO 2030
Forecast of the Largest Fractionators by Capacity
Forecast of Regional Distribution of Front Fractionation Capacity
New Government or National Fractionation Plants to Support Local Product Needs
THERAPEUTIC PLASMA PROTEINS PRODUCTION FORECAST
NORTH AMERICA PLANT PROFILES
EUROPE PLANT PROFILES
ASIA & PACIFIC PLANT PROFILES
CHINA PLANT PROFILES
MIDDLE EAST & AFRICA PLANT PROFILES
LATIN AMERICA PLANT PROFILES
SAMPLE PAGE
COUNTRY ZZZZ
NAME XYZ PHARMACEUTICAL CO.
ADDRESS 111 MAIN ROAD
CITY AAA
STATE/POSTAL CODE 000 BBBB
TELEPHONE +86 111 0000 1234
EMAIL ABCD@gmail.com
WEBSITE www.xyz.com
CHIEF EXECUTIVE OFFICER XXX
OWNERSHIP ABCDE HOLDING
STATUS COMMERCIAL
NUMBER OF EMPLOYEES
(PLASMA DERIVATIVES PRODUCTION & SALES) 0,000
PLANT CAPACITY
(LITERS X 000) 00
PLASMA PROCESSED (LITERS X 000)
PLASMAPHERESIS 000
RECOVERED PLASMA 000
TOTAL LITERS FRACTIONATED 000
MAIN PRODUCTS ALBUMIN, IVIG, IMIG, FACTOR VIII, FACTOR IX, PCC
NEW PRODUCTS INTRODUCED SINCE 2018: Any New Products